JENNIFER HANCOCK: Open Payments
NPI 1164091542 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 17 payments from 8 companies in 2025. Trend: 2023 $856 · 2024 $558 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $172 |
| Teva Pharmaceuticals USA, Inc. | 3 | $83 |
| ABBVIE INC. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Alkermes, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Indivior Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: REXULTI, AUSTEDO XR, VRAYLAR, SPRAVATO, ARISTADA, ABILIFY MAINTENA, INGREZZA, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
